| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.04 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.04 |